Novara Platinum CROMium Everolimus EluTing StEnt SpontaneoUs RegiStry
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fracture of Stent of Coronary Artery
- Sponsor
- Azienda Ospedaliero Universitaria Maggiore della Carita
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- QCA : nominal stent lenght ratio
- Last Updated
- 11 years ago
Overview
Brief Summary
Recent reports have described cases of novel thin-strut coronary stent longitudinal deformation during or after deployment and a biomechanical analysis have suggested increased susceptibility for such a complication for the platinum chromium (PtCr) coronary stent platforms . This analysis aims to assess the incidence of longitudinal stent deformation for PtCr stents in a large single centre all-comers population using quantitative angiographic analysis (QCA).
Detailed Description
Aims: Recent reports have described cases of novel thin-strut coronary stent longitudinal deformation during or after deployment and a biomechanical analysis have suggested increased susceptibility for such a complication for the platinum chromium (PtCr) coronary stent platforms . The aim of this analysis is to assess the incidence of longitudinal stent deformation for PtCr stents in a large single centre all-comers population . Methods: Quantitative angiographic analysis (QCA) of PtCr stents deployed in consecutive all-comers patients treated in our Laboratory from January 2011 to August 2012 will be performed by an independent core laboratory. In particular QCA : nominal stent lenght ratio will be calculated for every PtCr stent. Clinical follow up with data about overall and cardiac mortality, myocardial infarction and target vessel revascularization will also be performed.
Investigators
Lupi Alessandro
M.D.
Azienda Ospedaliero Universitaria Maggiore della Carita
Eligibility Criteria
Inclusion Criteria
- •PCI with at least 1 platinum-chromium platform-based stent
- •presence of at least 2 ortogonal angiographic projections of the deployed stent to allow proper quantitative coronary angiography
Exclusion Criteria
- •age \<18 \>90
Outcomes
Primary Outcomes
QCA : nominal stent lenght ratio
Time Frame: 1 day
QCA measured lenght of the deployed stent divided for the nominal stent lenght, a surrogate marker for stent deformation
Secondary Outcomes
- cardiovascular mortality(1 year)
- myocardial infarction(1 year)
- target vessel failure(1 year)
- Macroscopical stent deformation(1 day)